Biomarkers in Multiple Myeloma

Clinical trial NCT05259553 · RECRUITING

Trial details

NCT number: NCT05259553
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematological Patients Newly Diagnosed Multiple Myeloma Chemotherapy

Start date: 2022-05-20
Primary completion: 2025-10-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.